Improving Patient Compliance: A Major Goal in the Management of Hypertension
Authors:
Open Access
- 1 March 2003
- journal article
- review article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 5 (2) , 127-132
Abstract
The primary goal in the treatment of hypertension is to reduce the incidence of cardiovascular events in hypertensive patients. Studies performed to assess the impact of treating hypertension have revealed very disappointing reductions in the incidence of coronary heart disease. There are several reasons for these poor reductions in the incidence of cardiovascular disease; however, the most important is related to the fact that worldwide less than one quarter of hypertensive patients are adequately controlled for hypertension. Again, there are multiple reasons for these poor blood pressure (BP) control rates; however, most physicians would agree that patient compliance with their antihypertensive treatment is a major contributing factor. This is an area that we need to re focus on in our management of hypertensive patients. Issues such as safety, convenience, polypharmacy, cost, and education in the selection of antihypertensive agents are all critically important issues in the treatment of hypertensive patients. In addition, the level of patient involvement in their treatment seems to be essential in obtaining goal BP. Newer approaches to the management of hypertension such as earlier control of BP and the more aggressive use of low‐dose combination therapy as first‐line treatment of hypertension also need to be considered in our effort to improve BP control rates. Achieving goal BP in hypertensive patients is one of the most important clinical dilemmas facing physicians. There is little doubt that an improvement in control rates will result in substantial reductions in cardiovascular disease.Keywords
This publication has 28 references indexed in Scilit:
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- Changes in Antihypertensive Therapy - The Role of Adverse Effects and ComplianceBlood Pressure, 1998
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1997
- Hypertension awareness, treatment and control in the community: is the ‘rule of halves’ still valid?Journal of Human Hypertension, 1997
- Blood Pressure and Mortality Among Men With Prior Myocardial InfarctionCirculation, 1995
- Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom populationBMJ, 1995
- Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US PopulationHypertension, 1995
- The Costs of Interrupting Antihypertensive Drug Therapy in a Medicaid PopulationMedical Care, 1994
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990